Cancer drug design and discovery / (Record no. 246870)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02558cam a2200481Mi 4500 |
001 - CONTROL NUMBER | |
control field | ocn868955791 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | OCoLC |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20190328114807.0 |
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
fixed length control field | m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr cn||||||||| |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 131014t20142014ne a ob 001 0 eng d |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | E7B |
Language of cataloging | eng |
Description conventions | rda |
-- | pn |
Transcribing agency | E7B |
Modifying agency | OCLCO |
-- | N$T |
-- | OPELS |
-- | YDXCP |
-- | MYG |
-- | OCLCF |
-- | NKT |
-- | OCLCQ |
-- | U3W |
-- | D6H |
-- | AU@ |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780123972286 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0123972280 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9780123965219 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 0123965217 |
Qualifying information | (electronic bk.) |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
Canceled/invalid ISBN | 9780123965219 |
035 ## - SYSTEM CONTROL NUMBER | |
System control number | (OCoLC)868955791 |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RS431.A64 |
Item number | N45 2014eb |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | TEC |
Subject category code subdivision | 040000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.7/98 |
Edition number | 23 |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 673 |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Neidle, Stephen, |
Relator term | editor. |
245 10 - TITLE STATEMENT | |
Title | Cancer drug design and discovery / |
Medium | [electronic resource] |
Statement of responsibility, etc. | Stephen Neidle, School of Pharmacy, University College London, UK. |
250 ## - EDITION STATEMENT | |
Edition statement | 2nd ed. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Place of production, publication, distribution, manufacture | Amsterdam : |
Name of producer, publisher, distributor, manufacturer | Elsevier, |
Date of production, publication, distribution, manufacture, or copyright notice | [2014] |
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | �2014 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1 online resource (673 pages) : |
Other physical details | illustrations |
336 ## - CONTENT TYPE | |
Content type term | text |
Content type code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media type term | computer |
Media type code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier type term | online resource |
Carrier type code | cr |
Source | rdacarrier |
504 ## - BIBLIOGRAPHY, ETC. NOTE | |
Bibliography, etc | Includes bibliographical references and index. |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | Part 1. Basic principles and methodology -- part II. Drugs in the laboratory and clinic -- part III. The reality of cancerdrugs in the clinic. |
588 0# - SOURCE OF DESCRIPTION NOTE | |
Source of description note | Online resource; title from PDF title page (ebrary, viewed October 28, 2013). |
520 ## - SUMMARY, ETC. | |
Summary, etc. | Cancer Drug Design and Discovery, Second Edition is an important reference on the underlying principles for the design and subsequent development of new anticancer small molecule agents. New chapters have been added to this edition on areas of particular interest and therapeutic promise, including cancer genomics and personalized medicine, DNA-targeted agents and more. This book includes several sections on the basic and applied science of cancer drug discovery and features those drugs that are now approved for human use and are in the marketplace, as well as those that are still under develo. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antineoplastic agents |
General subdivision | Design. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Cancer |
General subdivision | Chemotherapy. |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | TECHNOLOGY & ENGINEERING |
General subdivision | Technical & Manufacturing Industries & Trades. |
Source of heading or term | bisacsh |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Antineoplastic agents |
General subdivision | Design. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst00810598 |
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Cancer |
General subdivision | Chemotherapy. |
Source of heading or term | fast |
Authority record control number | (OCoLC)fst00845327 |
655 #4 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Materials specified | ScienceDirect |
Uniform Resource Identifier | http://www.sciencedirect.com/science/book/9780123965219 |
No items available.